Shanghai Henlius Biotech, Inc. (2696.HK)

HKD 40.35

(3.59%)

Operating Expenses Summary of Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.'s latest annual operating expenses in 2023 was 3.28 Billion CNY , up 17.16% from previous year.
Shanghai Henlius Biotech, Inc.'s latest quarterly operating expenses in 2024 Q2 was 771.31 Million CNY , down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported a annual operating expenses of 2.72 Billion CNY in annual operating expenses 2022, up 53.05% from previous year.
Shanghai Henlius Biotech, Inc. reported a annual operating expenses of 1.78 Billion CNY in annual operating expenses 2021, up 37.67% from previous year.
Shanghai Henlius Biotech, Inc. reported a quarterly operating expenses of 771.31 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported a quarterly operating expenses of 3.19 Billion CNY for 2023 FY, up 17.16% from previous quarter.

Annual Operating Expenses Chart of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Historical Annual Operating Expenses of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	3.28 Billion CNY	17.16%
2022	2.72 Billion CNY	53.05%
2021	1.78 Billion CNY	37.67%
2020	1.29 Billion CNY	57.76%
2019	820.9 Million CNY	79.02%
2018	458.54 Million CNY	33.36%
2017	343.85 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	771.31 Million CNY	-16.42%
2024 Q2	771.31 Million CNY	0.0%
2023 FY	3.19 Billion CNY	17.16%
2023 Q1	741.76 Million CNY	-21.96%
2023 Q4	922.81 Million CNY	16.2%
2023 Q3	794.19 Million CNY	7.07%
2023 Q2	741.76 Million CNY	0.0%
2022 Q4	950.54 Million CNY	30.81%
2022 Q3	726.68 Million CNY	22.71%
2022 Q2	592.18 Million CNY	0.0%
2022 Q1	592.18 Million CNY	-6.53%
2022 FY	2.72 Billion CNY	53.05%
2021 Q3	633.54 Million CNY	65.15%
2021 Q2	383.62 Million CNY	0.0%
2021 Q1	383.62 Million CNY	-11.97%
2021 FY	1.78 Billion CNY	37.67%
2021 Q4	633.54 Million CNY	0.0%
2020 FY	1.29 Billion CNY	57.76%
2020 Q4	435.76 Million CNY	0.0%
2020 Q2	245.59 Million CNY	0.0%
2020 Q1	245.59 Million CNY	-10.95%
2020 Q3	435.76 Million CNY	77.43%
2019 Q4	275.79 Million CNY	0.0%
2019 Q2	165.64 Million CNY	21.77%
2019 Q1	136.02 Million CNY	-2.3%
2019 FY	820.9 Million CNY	79.02%
2019 Q3	275.79 Million CNY	66.5%
2018 Q4	139.23 Million CNY	0.0%
2018 FY	458.54 Million CNY	33.36%
2018 Q3	139.23 Million CNY	13.33%
2018 Q2	122.85 Million CNY	91.15%
2018 Q1	64.26 Million CNY	0.0%
2017 FY	343.85 Million CNY	0.0%

Peer Operating Expenses Comparison of Shanghai Henlius Biotech, Inc.

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-911.258%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	-344.649%